Search for: "Federal, Inc." Results 761 - 780 of 57,533
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
The federal district court in Alexandria did not err in finding that a German company’s mark VAGISAN used on feminine care products was likely to cause confusion with Combe, Inc. [read post]
The case is pending before the Maryland Court of Appeals on a question certified from a Maryland federal court in a COVID-19 business interruption insurance lawsuit brought by clothing manufacturer, Tapestry, Inc. [read post]
7 Jun 2010, 9:59 pm by Patent Docs
Par Pharmaceutical, Inc., the Federal Circuit exercised its prerogative to illustrate its fractured jurisprudence on two issues, obviousness and inequitable conduct, in a (fortunately) nonprecedential decision. [read post]
26 Aug 2009, 9:59 pm
Plaintiff-Appellant Ortho-McNeil Pharmaceutical, Inc. owns the '221 patent, which relates to a tramadol and acetaminophen composition for use in prescription pain relief. [read post]
24 Feb 2009, 9:43 pm
Food and Drug Administration from approving the Abbreviated New Drug Application (ANDA) filed by Defendant-Appellant Teva Pharmaceuticals USA, Inc. [read post]
6 Sep 2011, 9:55 pm by Patent Docs
Noonan -- The Federal Circuit majority decision in Classen Immunotherapies, Inc. v. [read post]
20 Dec 2011, 6:58 am by Al Raymond
The Federal District Court for the District of Maine’s August 3, 2011 decision to adopt U.S. [read post]
12 Oct 2010, 9:59 pm by Patent Docs
§ 2201) in the Hatch-Waxman context in Teva Pharmaceuticals USA, Inc. v. [read post]
12 Dec 2011, 9:59 pm by Patent Docs
Noonan -- The Federal Circuit reversed the grant of a preliminary injunction in Warner Chilcott Labs. [read post]
3 Jul 2012, 7:41 am by The Federalist Society
Federal Election Commission, which struck down a ban in federal law against corporate spending in political campaigns. [read post]
9 Mar 2017, 2:55 am by Elisabeth C. Pope
Google, Inc, United States Court of Appeals, Federal Circuit, No. 2016-1755, 7 March 2017 appeared first on Kluwer Patent Blog. [read post]
27 Aug 2010, 3:48 pm by Eric Schweibenz
On August 27, 2010, the Federal Circuit issued its opinion in Pass & Seymour, Inc. v. [read post]
22 Dec 2014, 10:58 pm
Pursuant to Federal Food Drug, and Cosmetic Act (FDCA), manufacturers of generic medications are required to prove their drugs are the same as the brand-name equivalent in design and labeling. [read post]
15 Jul 2020, 4:15 am by Rebecca Tapscott
On July 8, the United States Court of Appeals for the Federal Circuit (CAFC), in Fitbit, Inc. v. [read post]